ITOC
iTonic Holdings Ltd.
NASDAQ · Healthcare · Medical - Specialties · CN
$3.71
−3.39%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 861.6K | 523.0K | 448.2K | 628.6K | 679.8K |
| Cost of Revenue | 423.7K | 195.7K | 103.3K | 157.8K | 121.6K |
| Gross Profit | 437.9K | 327.4K | 344.9K | 470.8K | 558.1K |
| Operating Expenses | |||||
| R&D Expense | 1.1M | 459.1K | 93.3K | 84.5K | 73.7K |
| SG&A Expense | 10.1M | 5.1M | 1.0M | 693.0K | 456.9K |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 11.2M | 5.5M | 1.1M | 777.5K | 530.6K |
| Cost and Expenses | 11.6M | 5.7M | 1.2M | 935.3K | 652.3K |
| Operating Income (EBIT) | (10.7M) | (5.2M) | (770.3K) | (306.7K) | 27.5K |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | (1.5M) | 88.6K | 131.5K | 46.2K | 43.5K |
| Non-Operating Income (excl Interest) | (163.9K) | — | (131.5K) | (46.2K) | (43.5K) |
| EBT (Pre-Tax Income) | (12.2M) | (5.1M) | (638.8K) | (260.5K) | 71.0K |
| Income Tax Expense | 40.3K | — | 21.8K | (19.3K) | (13.0K) |
| Bottom Line | |||||
| Net Income | (11.3M) | (5.1M) | (660.6K) | (241.2K) | 84.0K |
| Earnings from Cont. Ops | (12.3M) | (5.1M) | (660.6K) | (241.2K) | 84.0K |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (11.3M) | (5.1M) | (660.6K) | (241.2K) | 84.0K |
| Per Share | |||||
| Basic EPS | ($6.85) | ($5.12) | ($0.83) | ($0.27) | $0.09 |
| Diluted EPS | ($6.85) | ($5.12) | ($0.83) | ($0.27) | $0.09 |
| Revenue Per Share | $0.19 | $0.52 | $0.56 | $0.69 | $0.75 |
| Shares | |||||
| Basic Shares Outstanding | 4.5M | 1.0M | 795077 | 906250 | 906250 |
| Diluted Shares Outstanding | 4.5M | 1.0M | 795077 | 906250 | 906250 |
| Profitability Metrics | |||||
| EBITDA | (10.4M) | (5.2M) | (566.3K) | (197.4K) | 125.1K |
| D&A | 167.0K | 13.3K | 72.4K | 63.1K | 54.1K |
| EBIT | (10.6M) | (5.2M) | (638.8K) | (260.5K) | 71.0K |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026